Director Noel R. Holland filed a Form 4 with the SEC on November 17, 2026, disclosing a transaction in Columbia Financial, Inc./MD/ common stock dated November 13, 2026.
Key Highlights
- Transaction: 15.2706 shares of common stock were acquired at $11.16 per share on November 13, 2026, through the Columbia Bank Stock Based Deferral Plan.
- Deferral Plan Holdings: Following the transaction, Holland beneficially owns 29,862.7527 shares indirectly through the Stock-Based Deferral Plan.
- Direct Holdings: Holland directly holds 80,797 shares of common stock.
- Additional Indirect Holdings: 109,316 shares held indirectly through a SEP-IRA and 6,494 shares held indirectly via Stock Award V.
- Stock Options: Holland holds 183,246 fully vested stock options with an exercise price of $7.10, expiring July 23, 2029.
- Non-Discretionary Acquisition: The filing states the shares were purchased "on a non-discretionary basis" by the trustee of the Bank's rabbi trust.
Holland's Non-Discretionary Deferral Plan Purchase at Columbia Financial
According to the filing, director Noel R. Holland of Columbia Financial, Inc./MD/ (NASDAQ:CLBK) acquired 15.2706 shares of common stock on November 13, 2026, at a price of $11.16 per share. The filing states that the acquisition represents phantom stock purchased "on a non-discretionary basis" by the trustee of the Bank's rabbi trust, maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. The filing notes that stock unit interests under this plan "will be settled in shares of stock upon distribution to the reporting person."
Following the reported transaction, the filing discloses that Holland beneficially owns 29,862.7527 shares indirectly through the Stock-Based Deferral Plan. In addition, Holland directly holds 80,797 shares, 109,316 shares indirectly through a SEP-IRA, and 6,494 shares indirectly through Stock Award V. The stock awards under Stock Award V were granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan and are described in the filing as vesting "in one year on March 12, 2027."
The filing also reports that Holland holds 183,246 stock options with an exercise price of $7.10, granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan. These options are described as "fully vested and exercisable," with an expiration date of July 23, 2029. The Form 4 was signed by Thomas F. Splaine, Jr., acting as Power of Attorney, on November 17, 2026.
What Was Disclosed
Director Noel R. Holland reported a non-discretionary acquisition of 15.2706 shares of Columbia Financial common stock at $11.16 through a rabbi trust deferral plan on November 13, 2026, along with existing direct, IRA, and stock award holdings and 183,246 fully vested stock options.



Please wait processing your request...